Agreement to Convert Debt to Equity Sample Contracts
AGREEMENT TO CONVERT DEBT TO EQUITYAgreement to Convert Debt to Equity • April 3rd, 2023 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledApril 3rd, 2023 Company IndustryThis Agreement to Convert Debt to Equity (the “Agreement”) effective as of the 31st day of December, 2021 between 60° Pharmaceuticals, LLC, a limited liability company organized and operating under the laws of Washington, District of Columbia (“Company”), and Geoffrey Dow (“Creditor”), as follows:
AGREEMENT TO CONVERT DEBT TO EQUITYAgreement to Convert Debt to Equity • April 28th, 2023 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledApril 28th, 2023 Company IndustryThis Agreement to Convert Debt to Equity (the “Agreement”) is made as of the 3lst day of August, 2021 between 60° Pharmaceuticals, LLC, a limited liability company organized and operating under the laws of Washington, District of Columbia ( “Company"), and Dong Loock (“Creditor"), as follows:
AGREEMENT TO CONVERT DEBT TO EQUITYAgreement to Convert Debt to Equity • April 3rd, 2023 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledApril 3rd, 2023 Company IndustryThis Agreement to Convert Debt to Equity (the “Agreement”) is made effective as of the 31st day of December, 2021 between 60° Pharmaceuticals, LLC, a limited liability company organized and operating under the laws of Washington, District of Columbia ( “Company”), and Ty Miller (“Creditor”), as follows:
AGREEMENT TO CONVERT DEBT TO EQUITYAgreement to Convert Debt to Equity • May 6th, 2013 • Biologix Hair Inc. • Soap, detergents, cleang preparations, perfumes, cosmetics • Nevada
Contract Type FiledMay 6th, 2013 Company Industry JurisdictionThis Agreement to convert debt to equity (the “Agreement”) is made as of this 30th day of April, 2013 by and between PENDOLINO INVESTMENTS LTD. (the “Creditor”) and BIOLOGIX HAIR INC., a Nevada corporation (the “Company”)
AGREEMENT TO CONVERT DEBT TO EQUITYAgreement to Convert Debt to Equity • April 28th, 2023 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledApril 28th, 2023 Company IndustryThis Agreement to Convert Debt to Equity (the “Agreement”) effective as of the 31st day of December, 2021 between 60° Pharmaceuticals, LLC, a limited liability company organized and operating under the laws of Washington, District of Columbia (“Company”), and Geoffrey Dow (“Creditor”), as follows:
AGREEMENT TO CONVERT DEBT TO EQUITYAgreement to Convert Debt to Equity • January 31st, 2023 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 31st, 2023 Company IndustryThis Agreement to Convert Debt to Equity (the “Agreement”) is made effective as of the 31st day of December, 2021 between 60° Pharmaceuticals, LLC, a limited liability company organized and operating under the laws of Washington, District of Columbia ( “Company”), and Ty Miller (“Creditor”), as follows:
CONVERT DEBT TO EQUITYAgreement to Convert Debt to Equity • September 12th, 2025 • Falcon's Beyond Global, Inc. • Services-miscellaneous amusement & recreation
Contract Type FiledSeptember 12th, 2025 Company IndustryThis Agreement to Convert Debt to Equity (the “Conversion Agreement”) is entered into as of September 8, 2025, by and between Infinite Acquisitions Partners LLC (the “Creditor”) and Falcon’s Beyond Global, Inc. (the “Company”), on behalf of its subsidiaries.
AGREEMENT TO CONVERT DEBT TO EQUITYAgreement to Convert Debt to Equity • April 28th, 2023 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledApril 28th, 2023 Company IndustryThis Agreement to Convert Debt to Equity (the “Agreement”) is made effective as of the 31st day of December, 2021 between 60° Pharmaceuticals, LLC, a limited liability company organized and operating under the laws of Washington, District of Columbia ( “Company”), and Ty Miller (“Creditor”), as follows:
